Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations.
Tjalf ZiemssenKatja AkgunAnna CzłonkowskaAgnieszka AntosJan BembenekIwona Kurkowska-JastrzębskaAdam PrzybyłkowskiMarta SkowrońskaLukasz SmolinskiTomasz LitwinPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
Neurofilament light chain concentrations may be used as a marker of brain injury in Wilson's disease, in addition to the clinical and neuroimaging disease severity scales. © 2022 International Parkinson and Movement Disorder Society.